Technology: Gene therapy
Industry: Longevity
Headquarters: United States
Founded Date: 01.01.2013
Employees Number: 101-250
Funding Status: IPO
Investors Number: 20
Total Funding: $195 M
Estimated Revenue: $10M to $50M
Last Funding Date: 25 07 18
Last Funding Type: Series E

Visit Website
Register and Claim Ownership